2011年9月13-17日，国际预防自杀协会（IASP）第二十六届世界大会将在中国首都北京召开。这是IASP世界大会第二次在亚洲国家召开。近年来，亚洲国家尤其是中国，有关自杀的研究和预防工作取得了很大进展，越来越多的各界人士开始致力于自杀的研究和预防，同时也积极参与国际范围的自杀研究和预防工作，成为全世界自杀研究和预防领域的重要部分。中国的自杀研究与预防与其他国家一样，面临许多共同的挑战，中国特有的文化背景和经济政治变革使中国的自杀问题具有其独特的状况。中国是一个人口大国，也是自杀率相对较高的国家，中国自杀领域的研究资料对于发展中国家，乃至全世界的自杀研究资料无疑都是极大的充实和丰富。因此在中国召开本届IASP世界预防自杀大会具有特殊的意义。

本届大会将邀请世界各地自杀学、精神卫生学、公共卫生学等相关领域的专家和政府官员进行大会发言，使各界对国际上与自杀相关的预防和研究现状有所了解；同时丰富的研究报告将为所有置身于自杀研究和预防事业的同道们提供一个分享学术成果、交流工作经验的平台。

欲参加本届大会的人士请登录www.iaspchina.org查看更多详细信息，并且敬请随时关注我们的网站，我们会及时更新有关大会的最新信息。

会议论文投稿截止日期为2011年3月1日。

The 26th international congress of IASP will be held in Beijing, the capital of China through September 13th to 17th, 2011. It is the second time for the congress to be held in Asia. With the considerable progress in research on suicide, there has been great success in suicide prevention in Asia, especially in China. More and more people in China are engaging in suicide research locally and internationally. While China is facing many common challenges in suicide research and suicide prevention as other countries, it also has to address many other issues which are closely related to its unique culture and recent fast pace of economic and political reformation. China is currently a country with the largest population and relatively high suicide rate. With no doubt, the success of suicide research and prevention in China will contribute greatly to the global understanding of this important issue, which makes the Congress held in China especially meaningful.

Expertise in suicidology, psychiatry, and public health as well as governmental officials from all over the world will be invited to the Congress. Their presentations will provide an overview of suicide-related research in the world. The Congress will serve as a platform for those who are interested and working in the field of suicide prevention to share their research and experience.

Detailed information about the Congress is available and updated frequently from the website www.iaspchina.org .

The Institute of Mental Health (IMH), Peking University is a hospital integrating education, research and clinical services. It is designated by the World Health Organization as WHO/Beijing Mental Health Collaborating Center for Research and Training and by Chinese Center for Disease Control and Prevention (China-CDC) as the National Center for Mental Health. It also serves as the Base for Drug Clinical Trail and the Base for the Chinese National Continuing Medical Education in Psychiatry. Meanwhile, the Chinese Mental Health Journal and the Clinical Psychology Center of Peking University are affiliated with the Institute.

The inpatient services currently consist of general care units, pediatric wards, geriatric wards, clinical psychological division, a VIP ward, a day-care rehabilitation center, a comprehensive intervention center where medication, physiotherapy, and psychotherapy are provided. The outpatient service is provided by experienced psychiatrists specialized in general psychiatry, eating disorder, substance abuse, sleep disorder, age-related amnesia, and rehabilitation. Other psychiatric services including consultation-liaison, forensic, and clinical evaluation for disability are also available at IMH. Our services are open to both domestic and foreign patients.

Scientific achievement has been made in the National Key Laboratory for Mental Health in IMH. Research includes biological psychiatry, social psychiatry, child psychiatry, and psychiatric therapeutics, which has been awarded many times for its outstanding achievements.
IMH has kept open communication domestically and internationally to continuously improve clinical and academic training. As a teaching hospital of Peking University, the IMH undertakes all pedagogical tasks of psychiatry and educational reform. Meanwhile, we have successfully hosted many international academic conferences, including the first Asia-Pacific Regional Meeting of World Psychiatry Association (1997), the International Psychogeriatric Association--Beijing Joint Meeting (1999), the Asia-Pacific Regional Meeting of the Collegiums’ International Neuro-Psychopharmacologicum (CINP) (2004), the First World Congress on Cultural Psychiatry and the Seventh Annual Symposium of Chinese Society of Psychiatry (2006).

IMH has played an important role in the establishment of the first law on mental health in China. From 2004, in the national project for mental health service model reformation (Project 686), IMH has been responsible for the program design, organizing, training, evaluation and supervision. IMH has also provided help for many major public health incidents.